Cytomegalovirus disease prophylaxis in seronegative recipients of kidneys from seropositive donors by combination of cytomegalovirus-hyperimmune globulin and low-dose acyclovir.
MacDonald
A S
AS
Transplant Service, Dalhousie University, Victoria General Hospital, Halifax, Nova Scotia, Canada.
Belitsky
P
P
Cohen
A
A
Lee
S
S
D000212:Acyclovir / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive; D016030:Kidney Transplantation; D014019:Tissue Donors
D000212:Acyclovir